Literature DB >> 26726307

TNFα in liver fibrosis.

Yoon Mee Yang1, Ekihiro Seki1.   

Abstract

Hepatocyte death, inflammation, and liver fibrosis are the hallmarks of chronic liver disease. Tumor necrosis factor-α (TNFα) is an inflammatory cytokine involved in liver inflammation and sustained liver inflammation leads to liver fibrosis. TNFα exerts inflammation, proliferation, and apoptosis. However, the role of TNFα signaling in liver fibrosis is not fully understood. This review highlights the recent findings demonstrating the molecular mechanisms of TNFα and its downstream signaling in liver fibrosis. During the progression of liver fibrosis, hepatic stellate cells play a pivotal role in a dynamic process of production of extracellular matrix proteins and modulation of immune response. Hepatic stellate cells transdifferentiate into activated myofibroblasts in response to damaged hepatocyte-derived mediators and immune cell-derived cytokines/chemokines. Here, we will discuss the role of TNFα in hepatic stellate cell survival and activation and the crosstalk between hepatic stellate cells and hepatocytes or other immune cells, such as macrophages, dendritic cells, and B cells in the development of liver fibrosis.

Entities:  

Keywords:  Liver fibrosis; TNFα; hepatic stellate cell; hepatocyte; macrophage

Year:  2015        PMID: 26726307      PMCID: PMC4693602          DOI: 10.1007/s40139-015-0093-z

Source DB:  PubMed          Journal:  Curr Pathobiol Rep        ISSN: 2167-485X


  83 in total

1.  Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.

Authors:  Toni Urbanik; Regina Johanna Boger; Thomas Longerich; Katharina Becker; Karl Roland Ehrenberg; Nadine Hövelmeyer; Matthias Hahn; Marcus Schuchmann; Dirk Jäger; Ari Waisman; Marcus Alexander Wörns; Henning Schulze-Bergkamen
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

2.  Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine.

Authors:  C A Rivera; B U Bradford; K J Hunt; Y Adachi; L W Schrum; D R Koop; E R Burchardt; R A Rippe; R G Thurman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-07       Impact factor: 4.052

3.  Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.

Authors:  K Tomita; G Tamiya; S Ando; K Ohsumi; T Chiyo; A Mizutani; N Kitamura; K Toda; T Kaneko; Y Horie; J-Y Han; S Kato; M Shimoda; Y Oike; M Tomizawa; S Makino; T Ohkura; H Saito; N Kumagai; H Nagata; H Ishii; T Hibi
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

4.  Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice.

Authors:  Kaori Sudo; Yasuhiro Yamada; Hisataka Moriwaki; Kuniaki Saito; Mitsuru Seishima
Journal:  Cytokine       Date:  2005-03-07       Impact factor: 3.861

Review 5.  TNF alpha and the TNF receptor superfamily: structure-function relationship(s).

Authors:  H T Idriss; J H Naismith
Journal:  Microsc Res Tech       Date:  2000-08-01       Impact factor: 2.769

6.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

7.  Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.

Authors:  Joy X Jiang; Xiangling Chen; Hiroo Fukada; Nobuko Serizawa; Sridevi Devaraj; Natalie J Török
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

8.  Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.

Authors:  Yuzo Kodama; Kojiro Taura; Kouichi Miura; Bernd Schnabl; Yosuke Osawa; David A Brenner
Journal:  Gastroenterology       Date:  2009-01-06       Impact factor: 22.682

9.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

Review 10.  IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.

Authors:  Mads Gyrd-Hansen; Pascal Meier
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

View more
  37 in total

1.  Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells.

Authors:  Nan Wu; Kelly McDaniel; Tianhao Zhou; Sugeily Ramos-Lorenzo; Chaodong Wu; Li Huang; Demeng Chen; Tami Annable; Heather Francis; Shannon Glaser; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-31       Impact factor: 4.052

2.  Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells.

Authors:  Cleverson Moraes de Oliveira; Leo Anderson Meira Martins; Arieli Cruz de Sousa; Ketlen da Silveira Moraes; Bruna Pasqualotto Costa; Moema Queiroz Vieira; Bárbara Paranhos Coelho; Radovan Borojevic; Jarbas Rodrigues de Oliveira; Fátima Costa Rodrigues Guma
Journal:  Mol Cell Biochem       Date:  2020-10-19       Impact factor: 3.396

3.  Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.

Authors:  Asmaa A Ashour; Amal H El-Kamel; Doaa A Abdelmonsif; Hoda M Khalifa; Alyaa A Ramadan
Journal:  Int J Nanomedicine       Date:  2021-12-08

4.  Activation of AT2 receptors prevents diabetic complications in female db/db mice by NO-mediated mechanisms.

Authors:  Fernando P Dominici; Luciana C Veiras; Justin Z Y Shen; Ellen A Bernstein; Diego T Quiroga; Ulrike M Steckelings; Kenneth E Bernstein; Jorge F Giani
Journal:  Br J Pharmacol       Date:  2020-09-13       Impact factor: 8.739

5.  Somatostatin analogue, Octreotide, improves restraint stress-induced liver injury by ameliorating oxidative stress, inflammatory response, and activation of hepatic stellate cells.

Authors:  Neven Makram Aziz; Merhan Mamdouh Ragy; Sabreen Mahmoud Ahmed
Journal:  Cell Stress Chaperones       Date:  2018-08-14       Impact factor: 3.667

Review 6.  Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis.

Authors:  Ling Nie; Yong Liu; Bo Zhang; Jinghong Zhao
Journal:  Kidney Dis (Basel)       Date:  2020-03-26

7.  Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.

Authors:  Matthew M Cousins; Theresa P Devasia; Christopher M Maurino; Justin Mikell; Matthew J Schipper; Ravi K Kaza; Theodore S Lawrence; Kyle C Cuneo; Yuni K Dewaraja
Journal:  J Nucl Med       Date:  2021-09-09       Impact factor: 11.082

8.  Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.

Authors:  Yuta Kasagi; Kara Dods; Joshua X Wang; Prasanna M Chandramouleeswaran; Alain J Benitez; Fiona Gambanga; Jonathan Kluger; Tokunbo Ashorobi; Jonathan Gross; John W Tobias; Andres J Klein-Szanto; Jonathan M Spergel; Antonella Cianferoni; Gary W Falk; Kelly A Whelan; Hiroshi Nakagawa; Amanda B Muir
Journal:  J Allergy Clin Immunol       Date:  2018-12-20       Impact factor: 14.290

Review 9.  Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis.

Authors:  Mehmet Sayiner; Brian Lam; Pegah Golabi; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2018-11-15       Impact factor: 4.409

10.  Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis.

Authors:  Wei Hou; Wing-Kin Syn
Journal:  Front Cell Dev Biol       Date:  2018-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.